At a glance
- Originator LEO Pharma
- Developer Cephalon; LEO Pharma
- Class Antineoplastics; Vitamins
- Mechanism of Action Brain derived neurotrophic factor modulators; Nerve growth factor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Neurological disorders
Most Recent Events
- 25 Jul 2001 Discontinued-Preclinical for Neurological disorders in Denmark (Unknown route)
- 25 Jul 2001 Discontinued-Preclinical for Neurological disorders in USA (Unknown route)